DaVita Inc. - DVA

SEC Filings Our DVA Tweets

About Gravity Analytica

Recent News

  • 11.03.2026 - DaVita Inc. to Participate in Upcoming Investor Conferences
  • 10.29.2026 - DaVita Inc. 3rd Quarter 2026 Results
  • 10.27.2026 - DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks
  • 10.20.2026 - DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice
  • 10.19.2026 - DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call
  • 10.15.2026 - DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care
  • 10.08.2026 - DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early
  • 08.25.2026 - DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease
  • 08.04.2026 - DaVita Inc. 2nd Quarter 2026 Results
  • 07.21.2026 - DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call

Recent Filings

  • 10.29.2026 - 4 Statement of changes in beneficial ownership of securities
  • 10.29.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 10.29.2026 - 8-K Current report
  • 10.29.2026 - EX-99.1 EX-99.1
  • 09.24.2026 - 4 Statement of changes in beneficial ownership of securities
  • 08.18.2026 - 4 Statement of changes in beneficial ownership of securities
  • 08.18.2026 - 4 Statement of changes in beneficial ownership of securities
  • 08.18.2026 - 4 Statement of changes in beneficial ownership of securities
  • 08.18.2026 - 4 Statement of changes in beneficial ownership of securities
  • 08.18.2026 - 4 Statement of changes in beneficial ownership of securities